Literature DB >> 1419031

The application of contrast agents in the evaluation of neoplasms of the central nervous system.

W T Yuh1, D J Fisher, H D Nguyen, E T Tali, N A Mayr.   

Abstract

Magnetic resonance evaluation of central nervous system neoplasms has improved tremendously since the introduction of gadolinium-based contrast agents. The optimal application of these agents in clinical imaging, however, has not been well established. The article discusses the recent application of these agents to a number of intracranial neoplasms, including metastases, gliomas, pituitary adenomas, and acoustic neurinomas/cerebellopontine angle tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419031

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  2 in total

1.  Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapy.

Authors:  Joseph A Spernyak; William H White; Manivannan Ethirajan; Nayan J Patel; Lalit Goswami; Yihui Chen; Steven Turowski; Joseph R Missert; Carrie Batt; Richard Mazurchuk; Ravindra K Pandey
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

2.  Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield.

Authors:  Or Cohen-Inbar; Zhiyuan Xu; Blair Dodson; Tanvir Rizvi; Christopher R Durst; Sugoto Mukherjee; Jason P Sheehan
Journal:  J Neurooncol       Date:  2016-08-27       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.